Grants

PI Name PI Organization Title Grant Number Initiative Program Director
Almonte, Maribel

International Agency For Res On Cancer
United States

 Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries 3UH3CA202730-05S1 Christos Patriotis, Ph.D., M.Sc.
Kohler, Jennifer J

Ut Southwestern Medical Center
United States

 New tools for studying GlcNAc biology 5U01CA242115-03 Guillermo Marquez, Ph.D.
Lopez-Bigas, Nuria

Fundacio Institut De Recerca Biomedica
United States

 PROMINENT - IRB 1OT2CA278668-01 Sharmistha Ghosh-Janjigian, Ph.D.
Glickson, Jerry D

University Of Pennsylvania
United States

 Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition 5R01CA228457-04
Patel, Abhijit

Yale University
United States

 Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood 5U01CA233364-05 Lynn Sorbara, Ph.D.
Mehta, Anand S

Medical University Of South Carolina
United States

 Glycopathology of HCC: identification of the source cells of serum fucosylation 5U01CA226052-05 PAR-17-206 (U01)
Oberg, Ann Laura

Mayo Clinic Rochester
United States

 Management and Data Coordination Unit for PCDC 1U24CA274496-01 PAR-21-335 (U24 Clinical Trial Not Allowed) Guillermo Marquez, Ph.D.
Oberg, Ann Laura

Mayo Clinic Rochester
United States

 Management and Data Coordination Unit for PCDC 1U24CA274496-01 PAR-21-335 (U24 Clinical Trial Not Allowed) Guillermo Marquez, Ph.D.
Wei, Chia-Lin

Jackson Laboratory
United States

 Advancing Ultra Long-read Sequencing and Chromatin Interaction Analyses for Chromosomal and Extrachromosomal Structural Variation Characterization in Cancer 1R33CA236681-01A1 RFA-CA-19-020 (R33 Clinical Trials Not Allowed) Lynn Sorbara, Ph.D.
Counter, Christopher M

Duke University
United States

 Adapting K-MDS to detect KRAS-mutant ctDNA 1R21CA257816-01A1 RFA-CA-21-003 (R21 Clinical Trial Not Allowed) Lynn Sorbara, Ph.D.